180 related articles for article (PubMed ID: 25429418)
1. Does background parenchymal enhancement on MRI affect the rate of positive resection margin in breast cancer patients?
Park SY; Kang DK; Kim TH
Br J Radiol; 2015 Feb; 88(1046):20140638. PubMed ID: 25429418
[TBL] [Abstract][Full Text] [Related]
2. Identification of Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Breast Cancer: A Retrospective Study.
Kang JH; Youk JH; Kim JA; Gweon HM; Eun NL; Ko KH; Son EJ
Korean J Radiol; 2018; 19(5):897-904. PubMed ID: 30174479
[TBL] [Abstract][Full Text] [Related]
3. Background parenchymal enhancement on breast MRI and mammographic breast density: correlation with tumour characteristics.
Kim MY; Choi N; Yang JH; Yoo YB; Park KS
Clin Radiol; 2015 Jul; 70(7):706-10. PubMed ID: 25824280
[TBL] [Abstract][Full Text] [Related]
4. Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.
Lim Y; Ko ES; Han BK; Ko EY; Choi JS; Lee JE; Lee SK
Breast Cancer Res Treat; 2017 Jun; 163(3):573-586. PubMed ID: 28349273
[TBL] [Abstract][Full Text] [Related]
5. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
[TBL] [Abstract][Full Text] [Related]
6. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
[TBL] [Abstract][Full Text] [Related]
7. MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
Bennani-Baiti B; Dietzel M; Baltzer PA
PLoS One; 2016; 11(7):e0158573. PubMed ID: 27379395
[TBL] [Abstract][Full Text] [Related]
8. The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
Vreemann S; Gubern-Mérida A; Borelli C; Bult P; Karssemeijer N; Mann RM
PLoS One; 2018; 13(1):e0191399. PubMed ID: 29351560
[TBL] [Abstract][Full Text] [Related]
9. Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer.
Li J; Mo Y; He B; Gao Q; Luo C; Peng C; Zhao W; Ma Y; Yang Y
Br J Radiol; 2019 Nov; 92(1103):20190417. PubMed ID: 31398071
[TBL] [Abstract][Full Text] [Related]
10. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.
Preibsch H; Richter V; Bahrs SD; Hattermann V; Wietek BM; Bier G; Kloth C; Blumenstock G; Hahn M; Staebler A; Nikolaou K; Wiesinger B
Eur J Radiol; 2017 May; 90():181-187. PubMed ID: 28583631
[TBL] [Abstract][Full Text] [Related]
11. No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Yoon TI; Lee JW; Lee SB; Sohn G; Kim J; Chung IY; Kim HJ; Ko BS; Son BH; Gong G; Kim SB; Kim SS; Ahn SD; Chung M; Ahn SH
Cancer Res Treat; 2018 Jan; 50(1):275-282. PubMed ID: 28421725
[TBL] [Abstract][Full Text] [Related]
12. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.
Price ER; Brooks JD; Watson EJ; Brennan SB; Comen EA; Morris EA
Eur Radiol; 2014 Jan; 24(1):162-8. PubMed ID: 23982290
[TBL] [Abstract][Full Text] [Related]
13. Background parenchymal enhancement over exam time in patients with and without breast cancer.
Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
[TBL] [Abstract][Full Text] [Related]
15. Impact of radiotherapy on background parenchymal enhancement in breast magnetic resonance imaging.
Kim YJ; Kim SH; Choi BG; Kang BJ; Kim HS; Cha ES; Song BJ
Asian Pac J Cancer Prev; 2014; 15(7):2939-43. PubMed ID: 24815428
[TBL] [Abstract][Full Text] [Related]
16. Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer.
You C; Gu Y; Peng W; Li J; Shen X; Liu G; Peng W
Acta Radiol; 2018 Jul; 59(7):806-812. PubMed ID: 29065702
[TBL] [Abstract][Full Text] [Related]
17. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
18. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
[TBL] [Abstract][Full Text] [Related]
19. Correlation of background parenchymal enhancement on breast MRI with breast cancer.
Sallam H; Lenga L; Solbach C; Becker S; Vogl TJ
Clin Radiol; 2023 Sep; 78(9):e654-e659. PubMed ID: 37330320
[TBL] [Abstract][Full Text] [Related]
20. MRI Texture Analysis of Background Parenchymal Enhancement of the Breast.
Amano Y; Woo J; Amano M; Yanagisawa F; Yamamoto H; Tani M
Biomed Res Int; 2017; 2017():4845909. PubMed ID: 28812015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
